BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 25618119)

  • 41. Surgical implications for liver metastases in nephroblastoma--data from the SIOP/GPOH study.
    Fuchs J; Szavay P; Luithle T; Furtwängler R; Graf N
    Surg Oncol; 2008 Jul; 17(1):33-40. PubMed ID: 17935976
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Minichromosome maintenance 2 (MCM2) is a new prognostic proliferative marker in Wilms tumour.
    Taran K; Sitkiewicz A; Andrzejewska E; Kobos J
    Pol J Pathol; 2011; 62(2):84-8. PubMed ID: 21866463
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Risk factors for perioperative complications in renal surgery for Wilms' tumor].
    Seseke F; Rebmann S; Zöller G; Lakomek M; Ringert RH
    Aktuelle Urol; 2007 Jan; 38(1):46-51. PubMed ID: 17290329
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Complete necrosis induced by preoperative chemotherapy in Wilms tumor as an indicator of low risk: report of the international society of paediatric oncology (SIOP) nephroblastoma trial and study 9.
    Boccon-Gibod L; Rey A; Sandstedt B; Delemarre J; Harms D; Vujanic G; De Kraker J; Weirich A; Tournade MF
    Med Pediatr Oncol; 2000 Mar; 34(3):183-90. PubMed ID: 10696124
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group.
    Mitchell C; Pritchard-Jones K; Shannon R; Hutton C; Stevens S; Machin D; Imeson J; Kelsey A; Vujanic GM; Gornall P; Walker J; Taylor R; Sartori P; Hale J; Levitt G; Messahel B; Middleton H; Grundy R; Pritchard J;
    Eur J Cancer; 2006 Oct; 42(15):2554-62. PubMed ID: 16904312
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Late recurrence in children with Wilms' tumor.
    Büyükpamukçu M; Köksal Y; Varan A; Atahan L; Cağlar M; Akyüz C; Kutluk T; Büyükpamukçu N
    Turk J Pediatr; 2007; 49(2):226-30. PubMed ID: 17907529
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cystic nephroma, cystic partially differentiated nephroblastoma and cystic Wilms' tumor in children: a spectrum with therapeutic dilemmas.
    van den Hoek J; de Krijger R; van de Ven K; Lequin M; van den Heuvel-Eibrink MM
    Urol Int; 2009; 82(1):65-70. PubMed ID: 19172100
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic value of proliferating cell nuclear antigen in Wilms' tumour in children.
    Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kantorowicz S; Daszkiewicz P
    Eur J Surg Oncol; 2002 Feb; 28(1):67-71. PubMed ID: 11869017
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of Renal Function in Pediatric Patients After Treatment for Wilms' Tumor.
    Janeczko M; Niedzielska E; Pietras W
    Adv Clin Exp Med; 2015; 24(3):497-504. PubMed ID: 26467140
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Wilms' tumor: diagnosis and treatment in the 1990s.
    Shochat SJ
    Semin Pediatr Surg; 1993 Feb; 2(1):59-68. PubMed ID: 8062023
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased microvascular density predicts relapse in Wilms' tumor.
    Abramson LP; Grundy PE; Rademaker AW; Helenowski I; Cornwell M; Katzenstein HM; Reynolds M; Arensman RM; Crawford SE
    J Pediatr Surg; 2003 Mar; 38(3):325-30; discussion 325-30. PubMed ID: 12632343
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management and outcome of pediatric metastatic Wilms' tumor at the National Cancer Institute, Egypt.
    Elayadi M; Magdy S; Khalil E; Zekri W
    J Egypt Natl Canc Inst; 2020 Apr; 32(1):19. PubMed ID: 32372204
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol database.
    Brok J; Lopez-Yurda M; Tinteren HV; Treger TD; Furtwängler R; Graf N; Bergeron C; van den Heuvel-Eibrink MM; Pritchard-Jones K; Olsen ØE; de Camargo B; Verschuur A; Spreafico F
    Lancet Oncol; 2018 Aug; 19(8):1072-1081. PubMed ID: 29960848
    [TBL] [Abstract][Full Text] [Related]  

  • 54. From upfront nephrectomy to preoperative chemotherapy and back: a single institution experience in the treatment of Wilms tumor.
    Sultan I; Masarweh M; Ismael T; Al-Hussaini M; Almousa A; Ali HM; Rodriguez-Galindo C; Ghandour K
    J Pediatr Hematol Oncol; 2009 May; 31(5):333-8. PubMed ID: 19415012
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effectiveness of preoperative chemotherapy in Wilms' tumor: results of an International Society of Paediatric Oncology (SIOP) clinical trial.
    Lemerle J; Voute PA; Tournade MF; Rodary C; Delemarre JF; Sarrazin D; Burgers JM; Sandstedt B; Mildenberger H; Carli M
    J Clin Oncol; 1983 Oct; 1(10):604-9. PubMed ID: 6321673
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of relapsed Wilms tumour (WT) patients: experience with topotecan. A report from the SIOP Renal Tumour Study Group (RTSG).
    Mavinkurve-Groothuis AM; van den Heuvel-Eibrink MM; Tytgat GA; van Tinteren H; Vujanic G; Pritchard-Jones KL; Howell L; Graf N; Bergeron C; Acha T; Catania S; Spreafico F
    Pediatr Blood Cancer; 2015 Apr; 62(4):598-602. PubMed ID: 25546733
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential expression of the drug resistance markers DNA topoisomerase II alpha and glutathione S-transferase-pi in the histological compartments of Wilms' tumors.
    Granzen B; Efferth T; Keller U; Beniers AJ; Mertens R; Jakse G; Füzesi L
    Anticancer Res; 2001; 21(1B):771-6. PubMed ID: 11299842
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Wilms' tumor: a 25-year review of the role of preoperative chemotherapy.
    Capra ML; Walker DA; Mohammed WM; Kapila L; Barbor PR; Sokal M; Robson K; Hewitt M; Stewart R
    J Pediatr Surg; 1999 Apr; 34(4):579-82. PubMed ID: 10235327
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic value of p53 expression in Wilms' tumor in children.
    Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kontorowicz S; Daszkiewicz P
    Med Sci Monit; 2001; 7(6):1224-9. PubMed ID: 11687734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Near complete resolution of refractory, relapsed, metastatic Wilms' tumour in an adolescent with bevacizumab.
    Kumar S; Burney IA; Al-Moundhri MS
    J Coll Physicians Surg Pak; 2014 Mar; 24 Suppl 1():S71-2. PubMed ID: 24718015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.